AbCellera Biologics Inc.
Status: Publicly traded
Direct answer
AbCellera Biologics Inc. is publicly traded on NASDAQ under the ticker ABCL.
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in...
Can you invest in AbCellera Biologics Inc.?
Yes. AbCellera Biologics Inc. trades publicly on NASDAQ as ABCL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AbCellera Biologics Inc.
Detailed equity research is provided by MarketSnap.